| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0142(19960801)78:3<542::AID-CNCR23>3.0.CO;2-Y |
| P698 | PubMed publication ID | 8697402 |
| P2093 | author name string | Brock N | |
| P2860 | cites work | Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide | Q44058478 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 542-547 | |
| P577 | publication date | 1996-08-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | The history of the oxazaphosphorine cytostatics | |
| P478 | volume | 78 |
| Q62148283 | 3,5-Bis(arylidene)piperid-4-ones Containing 1,3,2-Oxazaphosphorinane Moieties: Synthesis and Antitumor Activity |
| Q39826501 | Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay |
| Q39339684 | Antineoplastic drugs and their analysis: a state of the art review |
| Q34226984 | Cyclophosphamide for the treatment of systemic lupus erythematosus |
| Q38077550 | Cytochrome P450-activated prodrugs |
| Q37933845 | Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation |
| Q34187201 | Immunomodulatory effects of cyclophosphamide and implementations for vaccine design |
| Q34749403 | Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo |
| Q35833848 | Murine model of chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation |
| Q37386327 | Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors |
| Q37330181 | Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. |
| Q37157777 | Seeking approval: present and future therapies for pemphigus vulgaris |
| Q37316653 | Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches. |
| Q38295983 | Targeted prodrug approaches for hormone refractory prostate cancer. |
| Q46287377 | Use of whole sheep red blood cells in ELISA to assess immunosuppression in vivo |
| Q28477876 | Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy |
Search more.